Skip to content
38

ibuflam 600

Skip it

Brand-locked demand (top 5 brands take 100% of clicks) — this niche doesn't clear our bar today.

Market size 26Growth 16Conversion 71Competition 26Returns 100Price range 46Avg price 48Brand share 0Review moat 73Quality gap 23

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Review moat

Good582.71

avg incumbent reviews — the moat a new listing must climb

Conversion

Good6.5%

search→purchase rate — share of searches ending in a sale

Avg price

Okay€11.75

avg listing price — sweet spot $15–$100

Price range

Okay€6.34–€22.32

cheapest to priciest tracked listing — scored on the share inside $15–$100

Market size

Okay€110K

€110K/yr · 145K searches

Competition

Okay69%

top-5 click share — leaders hold, buyers still browse

Quality gap

Bad4.6★

avg incumbent rating — lower means beatable quality

Growth

Bad-18.4%

90-day search growth — must beat 0% to launch

Brand share

Bad100%

top-5 brand share — brand-locked demand

Competition

The top 5 products take 69% of clicks — established leaders, but buyers still shop beyond them.

Brands

4 falling

Sellers

30

Top-5 brand share

100%

Open market

0%

  • Nurofen79%
  • ratiopharm16%
  • Neuralgin4%
  • Birsppy2%
  • Open — no brand owns it (0%)

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%10%€11K20%€22K30%€33K40%€44K101001K10K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 14 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 88 weeks — -18.4% search growth over the last 90 days.
4K3KSpike '25DecJanFebMarAprMayJunJulAugSepOctNovDecJanFebMarAprMayJun

Peak months: Oct · busiest ÷ quietest = 1.8×

Reviews

What buyers praise and complain about, mined from review topics.

What buyers love

Qualität insgesamt75%

“Gute Qualität”

beworben Vs Tatsächliches Produkt25%

“Funktioniert wie Gewünscht”

What buyers complain about

Schmerzlinderung – insgesamt100%

“Schmerzt Tabletten”

Top return reasons

Funktionalität insgesamt100%